Presenting clinical features and survival of current and previously reported true erythroleukaemia cases
| No of cases | Splenomegaly | Hepatomegaly | Pancytopenia | Circulating proerythroblasts | Survival (months) | |
|---|---|---|---|---|---|---|
| *One case had no hepatosplenomegaly at presentation, but did have hepatic, splenic, and renal infiltration with pronormoblasts at necropsy. | ||||||
| **Median of all cases with survival data (40 in total). | ||||||
| ND, not determined or individually reported. | ||||||
| Di Guglielmo 19282 | 1 | 1/1 | 1/1 | 1/1 | 1/1 | 2 |
| Lazzaro 193315 | 1 | 1/1 | 1/1 | 0/1 | 1/1 | 0.5 |
| Stodmeister 194116 | 1 | 1/1 | 1/1 | 0/1 | 1/1 | 0 |
| Mirchandani et al 198317 | 1 | 0/1 | 0/1 | 1/1 | 0/1 | 3 |
| Reiffers et al 198518 | 2 | 1/2* | 0/2* | 2/2 | 1/2 | 0.5, 1 |
| Ruvidic iet al 19865 | 1 | ND | ND | 1/1 | 0/1 | 0.5 |
| Griesser and Hornby 19876 | 11 | 0/11 | 1/11 | 11/11 | 7/11 | 0.5–4 |
| Kowal-Vern et al 199219 | 13 | ND | ND | ND | ND | 0.1–9 |
| Tsuji et al 199520 | 1 | 1/1 | 1/1 | 1/1 | 0/1 | 2 |
| Mazzella et al 199821 | 15 | ND | ND | ND | ND | 0.5–14.5 |
| Hasserjian et al 2000 | 2 | 2/2 | 1/2 | 2/2 | 1/2 | 0, 4 |
| Total | 49 | 7/20 (35%) | 6/20 (30%) | 19/21 (90%) | 12/21 (57%) | 1.5** |